Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Front Immunol ; 15: 1374829, 2024.
Article de Anglais | MEDLINE | ID: mdl-38915400

RÉSUMÉ

Introduction and aim: Psoriasis vulgaris is associated with a significant healthcare burden, which increases over time as the disease progresses. The aim of this retrospective, population-based registry study was to characterize healthcare resource utilization (HCRU) in patients with psoriasis using biologics and oral immunosuppressants (conventionals) in Finland. Materials and methods: The study cohort included all patients with a diagnosis of psoriasis vulgaris in the secondary healthcare setting between 2012-2018, who initiated a biologic (n=1,297) or conventional (n=4,753) treatment between 2013-2017. Data on primary and secondary HCRU were collected from nationwide healthcare registries. Results: The results indicated a remarkable decrease in contacts with a dermatologist after the treatment initiation among patients starting biologic (mean annual number of contacts 5.4 per person before and 2.3 after the initiation), but not conventional (3.3 and 3.2) treatment. For conventional starters there was a high level of contacts with a dermatologist surrounding times of treatment switching, which was not observed for biologic starters. Conclusion: Overall, primary and other secondary care contacts did not decrease after the initiation or switch of treatment. The results highlight the importance of thorough consideration of the most optimal treatment alternatives, considering the overall disease burden to patients and healthcare systems.


Sujet(s)
Produits biologiques , Acceptation des soins par les patients , Psoriasis , Enregistrements , Humains , Psoriasis/thérapie , Finlande/épidémiologie , Femelle , Mâle , Adulte d'âge moyen , Adulte , Études rétrospectives , Produits biologiques/usage thérapeutique , Acceptation des soins par les patients/statistiques et données numériques , Sujet âgé , Immunosuppresseurs/usage thérapeutique , Ressources en santé/statistiques et données numériques , Jeune adulte , Adolescent
2.
Acta Derm Venereol ; 103: adv00886, 2023 Mar 09.
Article de Anglais | MEDLINE | ID: mdl-36892511

RÉSUMÉ

Therapeutic options for psoriasis vulgaris have changed during recent decades with the introduction of biologics. Few nationwide studies are available on psoriasis treatment patterns, and those from Finland predate the use of biologics. The aim of this retrospective, population-based registry study was to identify patients with psoriasis vulgaris and their treatment patterns in the secondary care setting in Finland. The study cohort included 41,456 adults with a diagnosis of psoriasis vulgaris in the public secondary healthcare setting from 2012 through 2018. Data on comorbidities, pharmacotherapy, and phototherapy were collected from nationwide healthcare and drug registries. Patients in the cohort had a wide range of comorbidities, with 14.9% having psoriatic arthritis. Treatment was based largely on topical and conventional systemic medications. Conventional medications were used by 28.9% of patients, and methotrexate was the most common option (20.9%). Biologics were used by 7.3% of patients, mostly as second- and third-line treatment. The use of conventional systemic medications, topical treatments, and phototherapy decreased after the initiation of biologics. This study of psoriasis vulgaris in Finland provides a framework for the development of future care practices.


Sujet(s)
Produits biologiques , Psoriasis , Adulte , Humains , Finlande/épidémiologie , Études rétrospectives , Psoriasis/diagnostic , Psoriasis/traitement médicamenteux , Psoriasis/épidémiologie , Enregistrements , Produits biologiques/effets indésirables
3.
Scand J Public Health ; 34(6): 632-40, 2006.
Article de Anglais | MEDLINE | ID: mdl-17132597

RÉSUMÉ

STUDY OBJECTIVE: To (1) describe the setting and design of the Good Ageing in Lahti Region (GOAL) programme; (2) by using the baseline results of the GOAL cohort study, to examine whether living in urban, semi-urban, or rural communities is related to risk factors for chronic diseases and functional disability in ageing individuals. DESIGN: The baseline data of a cohort study of ageing individuals living in three community types (urban, semi-urban, rural). Data were collected by two questionnaires and laboratory assessments. SETTING: Fourteen municipalities in the Lahti region (Päijät-Häme County) in Finland. PARTICIPANTS: A regionally and locally stratified random sample of men and women born in 1946-50, 1936-40, and 1926-30. A total of 4,272 were invited and 2,815 (66%) participated. MAIN RESULTS: Elevated serum cholesterol, obesity, disability, sedentary lifestyle (<2 times/week walking), and high fat intake were more prevalent in rural vs. urban and semi-urban communities. After adjustment for sex, age, education, obesity, diet, physical activity, smoking, and alcohol use, rural communities remained the only community type with increased (p<0.05) probability for high BMI (OR 1.33) and high waist circumference (OR 1.43). CONCLUSIONS: The unfavourable health and lifestyle profile, together with an old population, makes health promotion for elderly citizens a special challenge for rural communities such as those in Päijät-Häme County, Finland. Most, if not all, of the differences in health between the three community types were explained by educational background, physical activity, and smoking.


Sujet(s)
Vieillissement , Comportement en matière de santé , Promotion de la santé , État de santé , Sujet âgé , Vieillissement/physiologie , Vieillissement/psychologie , Attitude envers la santé , Études de cohortes , Services de santé communautaires , Femelle , Finlande , Humains , Mode de vie , Mâle , Facteurs de risque , Population rurale , Facteurs socioéconomiques , Enquêtes et questionnaires , Population urbaine
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE